CYP1A1 and Sepsis: Altogether, these findings confirmed the regulatory effects of CYP1A1/12(S)-HETE/JNK/AP-1 axis in vivo, while Rhapontigenin reduces the mortality and pro-inflammatory biomarkers from sepsis.